Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 4, 2010, Pages 967-972

  Scholz, Claus Jürgen ^a   Jacob, Christian P ^a   Buttenschon, Henriette N ^b   Kittel Schneider, Sarah ^a   Boreatti Hümmer, Andrea ^a   Zimmer, Michael ^a   Walter, Ulrich ^a   Lesch, Klaus Peter ^a   Mors, Ole ^b   Kneitz, Susanne ^a   Deckert, Jürgen ^a   Reif, Andreas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Association; Bipolar disorder; GWAS; Haplotype; nsSNP; Replication; Schizophrenia; Tetraspanin

Indexed keywords

ALANINE; GLYCINE; TETRASPANIN; TRANSCRIPTION FACTOR; TSPAN8 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BINDING SITE; BIPOLAR DISORDER; COMPUTER MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIGENS, NEOPLASM; BIPOLAR DISORDER; CASE-CONTROL STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERVIEWS AS TOPIC; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MULTICENTER STUDIES AS TOPIC; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 77952684923     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31057     Document Type: Article

References (46)

1. Barrett JC, Fry B, Maller J, Daly MJ, 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 21(2):263-265.
2. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nöthen MM, et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13(2):197-207.
3. Berditchevski F, Odintsova E. 2007. Tetraspanins as regulators of protein trafficking. Traffic (Copenhagen, Denmark) 8(2):89-96.
4. Berrettini W. 2003. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet Part C 123C(1):59-64. (Pubitemid 37356433)
5. Bromberg Y, Rost B. 2007. SNAP: Predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res 35(11):3823-3835. (Pubitemid 47244674)
6. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T, 2005. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics (Oxford, England) 21(13):2933-2942.
7. Craddock N, O'Donovan MC, Owen MJ, 2005. The genetics of schizophrenia and bipolar disorder: Dissecting psychosis. J Med Genet 42(3):193-204. (Pubitemid 40380298)
8. Culhane AC, Thioulouse J, Perrière G, Higgins DG, 2005. MADE4: An R package for multivariate analysis of gene expression data. Bioinformatics (Oxford, England) 21(11):2789-2790.
9. De Bruyne E, Bos TJ, Asosingh K, Vande Broek I, Menu E, Van Valckenborgh E, Atadja P, Coiteux V, Leleu X, Thielemans K, et al. 2008. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival. Clin Cancer Res: An Official Journal of the American Association for Cancer Research 14(10):2918-2926.
10. Ferreira MAR, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9):1056-1058.
11. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, et al. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164):851-861.
12. Grarup N, Andersen G, Krarup NT, Albrechtsen A, Schmitz O, Jørgensen T, Borch-Johnsen K, Hansen T, Pedersen O, 2008. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 57(9):2534-2540.
13. Jarikji Z, Horb LD, Shariff F, Mandato CA, Cho KWY, Horb ME, 2009. The tetraspanin Tm4sf3 is localized to the ventral pancreas and regulates fusion of the dorsal and ventral pancreatic buds. Development (Cambridge, England) 136(11):1791-1800.
14. Kirov G, Zaharieva I, Georgieva L, Moskvina V, Nikolov I, Cichon S, Hillmer A, Toncheva D, Owen MJ, O'Donovan MC, 2008. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry 14(8):796-803. (Pubitemid 351444532)
15. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucherlapati R, Malhotra AK, 2007. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12(6):572-580. (Pubitemid 46816774)
16. Levy S, Shoham T. 2005. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5(2):136-148. (Pubitemid 40208903)
17. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM, 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373(9659):234-239.
18. Lundorf MD, Buttenschon HN, Foldager L, Blackwood DH, Muir WJ, Murray V, Pelosi AJ, Kruse TA, Ewald H, Mors O, 2005. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet Part B 135B(1):94-101.
19. Mah S, Nelson MR, Delisi LE, Reneland RH, Markward N, James MR, Nyholt DR, Hayward N, Handoko H, Mowry B, et al. 2006. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol Psychiatry 11(5):471-478.
20. Maranduba CMdC, Sá Moreira E, Müller Orabona G, Pavanello RC, Vianna-Morgante AM, Passos-Bueno MR, 2004. Does the P172H mutation at the TM4SF2 gene cause X-linked mental retardation? Am J Med Genet Part A 124A(4):413-415.
21. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, et al. 2003. TRANSFAC: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31(1):374-378.
22. Menashe I, Rosenberg PS, Chen BE, 2008. PGA: Power calculator for case-control genetic association analyses. BMC Genet 9:36. (Pubitemid 351715983)
23. Miranti CK. 2009. Controlling cell surface dynamics and signaling: How CD82/KAI1 suppresses metastasis. Cell Signal 21(2):196-211.
24. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, O'Donovan MC, 2009. Gene-wide analyses of genome-wide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14(3):252-260.
25. Ng PC, Henikoff S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812-3814. (Pubitemid 37442253)
26. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40(9):1053-1055.
27. Porteous D. 2008. Genetic causality in schizophrenia and bipolar disorder: Out with the old and in with the new. Curr Opin Genet Dev 18(3):229-234.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575. (Pubitemid 47330214)
29. Ramensky V, Bork P, Sunyaev S, 2002. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 30(17):3894-3900. (Pubitemid 35012462)
30. R-Development-Core-Team. 2009. R: A Language and Environment for Statistical Computing. Version 2.9. Vienna, Austria: R Foundation for Statistical Computing.
31. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, et al. 2006. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11(3):286-300.
32. Reif A, Melchers M, Strobel A, Jacob CP, Herterich S, Lesch KP, Zimmer M, 2007. FZD3 is not a risk gene for schizophrenia: A case-control study in a Caucasian sample. J Neural Transm (Suppl 72): 297-301.
33. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S, 2006. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11(10):965-978. (Pubitemid 44470218)
34. Scholz C-J, Kurzeder C, Koretz K, Windisch J, Kreienberg R, Sauer G, Deissler H, 2009. Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. Cancer Lett 275(2):198-203.
35. Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R, Tozzi F, Li JZ, Burmeister M, Absher D, et al. 2009. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Aca Sci USA 106(18):7501-7506.
36. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, Craddock NJ, Kendler KS, Li T, O'Donovan M, O'Neill FA, et al. 2008. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4(2):e28-e28.
37. Sklar P, Smoller JW, Fan J, Ferreira MAR, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, et al. 2008. Whole -genome association study of bipolar disorder. Mol Psychiatry 13(6):558-569.
38. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460(7256):744-747.
39. Stipp CS, Kolesnikova TV, Hemler ME, 2003. Functional domains in tetraspanin proteins. Trends Biochem Sci 28(2):106-112.
40. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, et al. 2008. Genomewide association for schizophrenia in the CATIE study: Results of stage 1. Mol Psychiatry 13(6):570-584.
41. Van Snellenberg JX, de Candia T. 2009. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry 66(7):748-755.
42. WTCCC. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661-678.
43. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME, 2008. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68(9):3204-3213.
44. Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carrié A, Billuart P, McDonell N, Couvert P, Francis F, Chafey P, et al. 2000. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nature Genet 24(2):167-170.
45. Zhou Z, Ran Y-L, Hu H, Pan J, Li Z-F, Chen L-Z, Sun L-C, Peng L, Zhao X-L, Yu L, et al. 2008. TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clin Exp Metastasis 25(5):537-548.
46. Zöller M. 2009. Tetraspanins: Push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9(1):40-55.